Health

Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechanism Data in Gastrointestinal Stromal Tumors in Natures Signal Transduction and Targeted Therapy

Largest prospective clinical trial to-date in a rare subtype of GIST ROCKVILLE, Md. and SUZHOU, China, Nov. 24, 2025 (GLOBE…

2 months ago

DXS INTERNATIONAL PLC (AQSE: DXSP): Notice of 2025 Annual General Meeting

November 24, 2025 02:00 ET  | Source: DXS International PLC Monday 24 November DXS INTERNATIONAL PLC (AQSE: DXSP) Notice of…

2 months ago

ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025

EINDHOVEN, the Netherlands, Nov. 24, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology…

2 months ago

Sequana Medical Announces First U.S. Commercial alfapump Implantation at Mount Sinai Hospital in New York

Ghent, Belgium, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Milestone in bringing breakthrough treatment option to US patients with recurrent and…

2 months ago

Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citis 2025 Global Healthcare Conference in December

November 21, 2025 16:30 ET  | Source: Teva Pharmaceutical Industries Ltd TEL AVIV, Israel, Nov. 21, 2025 (GLOBE NEWSWIRE) --…

2 months ago

Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference

November 21, 2025 16:30 ET  | Source: Olema Oncology SAN FRANCISCO, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”,…

2 months ago

Conavi Medical Corp. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants

November 21, 2025 16:30 ET  | Source: Conavi Medical Corp. PRELIMINARY PROSPECTUS ACCESSIBLE ON SEDAR+ NOT FOR RELEASE OR DISTRIBUTION…

2 months ago

Sharecare wins 22 Digital Health Awards in Fall 2025 competition

Company earns five Golds for its NCQA-accredited health navigation platform, Diabetes Prevention Program, and patient education and engagement solutions November…

2 months ago

MAIA Biotechnology Highlights Ongoing Momentum of Ateganosine Clinical Program at SITC 2025

Company confirms 12 patients enrolled in Phase 2 THIO-101 to date as expansion trial adds new countries Posters for Phase…

2 months ago

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 21, 2025 09:00 ET  | Source: InspireMD Inc. MIAMI, Nov. 21, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR)…

2 months ago